Dpb Pharmaceuticals Limited, a active public limited company, was established on 20 April 2018 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24304MH2018PLC308316. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.05 Cr and a paid-up capital of ₹3.13 Cr.
Its leadership includes Devang Manharlal Ajmera (Director), Piyush Manharlal Ajmera (Director), Bhavin Manharlal Ajmera (Director). It holds ₹74.00 Cr open charges and ₹10.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 308,3Rd Floor,Exim Link,Indira Container Yard,Nr.Nahur Railway Station,Bhandup W, Mumbai, Maharashtra, 400078.
U24304MH2018PLC308316
308316
20 April 2018
₹5.05 Cr
₹3.13 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Dpb Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devang Manharlal Ajmera | Director | 20 Apr 2018 | Current |
| Piyush Manharlal Ajmera | Director | 20 Apr 2018 | Current |
| Bhavin Manharlal Ajmera | Director | 20 Apr 2018 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dpb Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.02% increase. The company also saw a substantial fall in profitability, with a 20.89% decrease in profit. The company's net worth Soared by an impressive increase of 40.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dpb Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹740,000,000.00
₹100,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Apr 2025 | Others | ₹24.00 Cr | Open |
| 26 Mar 2024 | Yes Bank Limited | ₹20.00 Cr | Open |
| 24 Jun 2022 | Others | ₹20.00 Cr | Open |
| 26 Apr 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹10.00 Cr | Open |
| 19 Aug 2022 | Hdfc Bank Limited | ₹10.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dpb Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dpb Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dpb Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 19 Aug 2022 via Charge ID 100614411 with Hdfc Bank Limited was fully satisfied on 24 Sep 2025. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 24.00 Cr with Charge ID 101085912 was registered on 02 Apr 2025. was documented.
Progress on Dpb Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Dpb Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Yes Bank Limited amounted to Rs. 20.00 Cr with Charge ID 100896709 was registered on 26 Mar 2024. was documented.
Progress on A charge with Others of Rs. 20.00 Cr registered on 24 Jun 2022 with Charge ID 100599342 was modified on 30 Apr 2023. was documented.
The CIN of Dpb Pharmaceuticals Limited is U24304MH2018PLC308316.
Dpb Pharmaceuticals Limited is headquartered at 308,3Rd Floor,Exim Link,Indira Container Yard,Nr.Nahur Railway Station,Bhandup W, Mumbai, Maharashtra, 400078.
Dpb Pharmaceuticals Limited was incorporated on 20 April 2018.
The current directors of Dpb Pharmaceuticals Limited are
The primary industry of Dpb Pharmaceuticals Limited is Trade.
Dpb Pharmaceuticals Limited is unlisted.
The authorized capital of Dpb Pharmaceuticals Limited is ₹5.05 Cr, and the paid-up capital is ₹3.13 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX